Form 4: Vita Coco Director Sells Shares Under 10b5-1 Plan

Vita Coco Company Director Kenneth Sadowsky sold 3,900 shares of common stock for approximately $38.915 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Kenneth Sadowsky, a Director of Vita Coco Company, Inc. (COCO), reported a sale of common stock.
• On October 15, 2025, Sadowsky disposed of 3,900 shares of common stock.
• The shares were sold at a weighted average price of $38.915, with individual transactions ranging from $38.64 to $39.16.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up pre-scheduled trades.
• Following this transaction, Sadowsky directly beneficially owns 619,966 shares of common stock.
• Sadowsky also holds 27,300 non-qualified stock options, fully vested and exercisable, with an exercise price of $10.178 and an expiration date of January 2, 2030.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan indicates a pre-scheduled transaction, not necessarily a signal of negative company performance or outlook. The director also retains substantial holdings.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can mitigate negative perceptions of insider selling.
• Kenneth Sadowsky retains a substantial beneficial ownership of 619,966 shares of common stock and 27,300 exercisable stock options, demonstrating continued alignment with shareholder interests.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, although the pre-planned nature reduces this impact.

Future Outlook

This filing, a Form 4, reports an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is specific to Vita Coco Company and its director. It does not provide direct insights into broader industry trends or competitor activities, beyond reflecting a director's portfolio management decisions within the consumer beverage sector.

Comparison to Industry Standards

• Insider sales executed under Rule 10b5-1 plans are a common practice across publicly traded companies, allowing executives and directors to diversify holdings or manage liquidity without concerns of trading on material non-public information. This transaction aligns with standard corporate governance practices for insider trading.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct holdings, but the pre-planned nature under Rule 10b5-1 suggests it is a routine portfolio management decision rather than a reflection of company-specific concerns. The director maintains significant ownership.

Key Dates

Recommendation

The reported transaction is a routine insider sale executed under a Rule 10b5-1 trading plan, which typically does not signal a change in the company's fundamental outlook. Investors should consider broader company performance, market conditions, and other financial disclosures rather than this isolated event when making investment decisions. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Vita Coco, COCO, Kenneth Sadowsky, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Common Stock, Equity Transaction